The Lead Episode 151: Heart Rhythm 2026 Late-Breaker Coverage: A Discussion of Outcomes of Left Atrial Appendage Closure versus Oral Anticoagulation in Patients with Atrial Fibrillation and Prior Ablation: A Sub-Analysis of the CHAMPION-AF Clinical Trial-The Lead Episode 151 Speaker Information

The Lead Episode 151 Speaker Information

Pdf Summary

This document is a brief conference title and presenter slide for a Heart Rhythm 2026 late-breaker discussion. It announces coverage of a sub-analysis from the CHAMPION-AF clinical trial comparing left atrial appendage closure with oral anticoagulation in patients with atrial fibrillation who have had prior ablation.<br /><br />The session is hosted by Sandeep A. Saha, MD, MS, FHRS of Oregon Heart Center PC. The contributors are Rakesh Gopinathannair, MBA, MD, FHRS of the Kansas City Heart Rhythm Institute, and Scott C. Brancato, MD, FHRS of The Oregon Clinic.<br /><br />The remainder of the document consists mainly of disclosure information. Scott C. Brancato reports no conflicts in one section, but also lists board/advisory roles with Heart Rhythm Society and AltaThera Pharmaceuticals, plus honoraria or consulting relationships with Abbott, Johnson & Johnson, Boston Scientific, and Sanofi. Rakesh Gopinathannair and Sandeep A. Saha list disclosures involving Medtronic, including board/advisory committee membership and honoraria/speaking/consulting activity.<br /><br />Overall, the document serves as an introductory and administrative slide rather than a scientific results summary.

Keywords

Heart Rhythm 2026

late-breaker discussion

CHAMPION-AF

left atrial appendage closure

oral anticoagulation

atrial fibrillation

prior ablation

clinical trial sub-analysis

disclosure information

Sandeep A. Saha